Evidence map›Paper›PMID 25889915›Full record

ArticleRadiation oncology (London, England)2015

Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX.

Jana Kroeber, Barbara Wenger, Manuela Schwegler, Christoph Daniel, Manfred Schmidt, Cholpon S Djuzenova, Bülent Polat, Michael Flentje, Rainer Fietkau, Luitpold V Distel

Open access · goldAbstract readComparative Study
In one paragraph

Article in Radiation oncology (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy.European journal of nuclear medicine and molecular imaging · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jana KroeberDepartment of Radiation Oncology, Friedrich-Alexander-University of Erlangen-Nürnberg, Universitätsstraße 27, D-91054, Erlangen, Germany. jana.kroeber@gmx.net.
Barbara WengerDepartment of Radiation Oncology, Friedrich-Alexander-University of Erlangen-Nürnberg, Universitätsstraße 27, D-91054, Erlangen, Germany. Barbara.Wenger@klinik.uni-regensburg.de.
Manuela SchweglerDepartment of Radiation Oncology, Friedrich-Alexander-University of Erlangen-Nürnberg, Universitätsstraße 27, D-91054, Erlangen, Germany. manuela.schwegler@uk-erlangen.de.
Christoph DanielDepartment of Nephropathology, University Hospitals and Friedrich-Alexander-University Erlangen-Nürnberg Institute of Pathology, 91054, Erlangen, Germany. christoph.daniel@uk-erlangen.de.
Manfred SchmidtDepartment of Radiation Oncology, Friedrich-Alexander-University of Erlangen-Nürnberg, Universitätsstraße 27, D-91054, Erlangen, Germany. manfred.schmidt@uk-erlangen.de.
Cholpon S DjuzenovaDepartment of Radiation Oncology, University of Würzburg, 97080, Würzburg, Germany. Djuzenova_T@ukw.de.
Bülent PolatDepartment of Radiation Oncology, University of Würzburg, 97080, Würzburg, Germany. polat_b@ukw.de.
Michael FlentjeDepartment of Radiation Oncology, University of Würzburg, 97080, Würzburg, Germany. Flentje_M@klinik.uni-wuerzburg.de.
Rainer FietkauDepartment of Radiation Oncology, Friedrich-Alexander-University of Erlangen-Nürnberg, Universitätsstraße 27, D-91054, Erlangen, Germany. rainer.fietkau@uk-erlangen.de.
Luitpold V DistelDepartment of Radiation Oncology, Friedrich-Alexander-University of Erlangen-Nürnberg, Universitätsstraße 27, D-91054, Erlangen, Germany. Luitpold.Distel@uk-erlangen.de.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years attention has focused on γH2AX as a very sensitive double strand break indicator. It has been suggested that γH2AX might be able to predict individual radiosensitivity. Our aim was to study the induction and repair of DNA double strand breaks labelled by γH2AX in a large cohort.

methodsIn a prospective study lymphocytes of 136 rectal cancer (RC) patients and 59 healthy individuals were ex vivo irradiated (IR) and initial DNA damage was compared to remaining DNA damage after 2 Gy and 24 hours repair time and preexisting DNA damage in unirradiated lymphocytes. Lymphocytes were immunostained with anti-γH2AX antibodies and microscopic images with an extended depth of field were acquired. γH2AX foci counting was performed using a semi-automatic image analysis software.

resultsDistinct increased values of preexisting and remaining γH2AX foci in the group of RC patients were found compared to the healthy individuals. Additionally there are clear differences within the groups and there are outliers in about 12% of the RC patients after ex vivo IR.

conclusionsThe γH2AX assay has the capability to identify a group of outliers which are most probably patients with increased radiosensitivity having the highest risk of suffering radiotherapy-related late sequelae.

Indexed as

DNA DamageDNA RepairAdultAgedAged, 80 and overCase-Control StudiesFemaleFluorescent Antibody TechniqueFollow-Up StudiesHistonesHumansLymphocytesMaleMiddle AgedProspective StudiesRadiation ToleranceH2AX protein, humanHistones

Identifiers

PMID25889915
PMCPMC4330982
OpenAlexW2121899721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.